Dihydromyricetin (DHM) Powder | CAS 27200-12-0 | ≥ 98.0% HPLC | Vine Tea Extract
Botanical Source: Ampelopsis grossedentata (Vine Tea) Leaves
CAS Number: 27200-12-0
Content Specification: ≥ 98.0% (HPLC)
Testing Method: HPLC
Appearance Profile: Light yellow powder
Shelf Life: 24 Months
Dihydromyricetin (DHM) API - 98% Pharmaceutical Purity
High-Precision Ingredient for Metabolic & Hepatic Research
Xi'an Tihealth Biotechnology Co., Ltd. offers this professional-grade 98% Dihydromyricetin (DHM) extract, meticulously purified for applications requiring extreme concentration. Unlike standardized extracts intended for mass-market nutraceuticals, this API-level powder is designed for drug candidate research, complex therapeutic delivery systems, and metabolic disease modeling.
Derived from high-yield Ampelopsis grossedentata, this specification undergoes advanced multi-stage column chromatography to remove secondary flavonoids and tannins. The resulting micro-crystalline powder ensures that researchers and formulators obtain exact molecular dosing for studies involving hepatic detoxification, anti-tumor signaling, and glucose regulation. Every batch is supported by comprehensive documentation, reflecting Tihealth's commitment to API-level quality consistency.
API Quality Standards
| Control Parameter | API Specification |
|---|---|
| Assay (HPLC) | ≥ 98.0% |
| Appearance | Light yellow crystalline powder |
| CAS Number | 27200-12-0 |
| Residue on Ignition | ≤ 0.5% |
Pharmacological Significance
01. Therapeutic Metabolism Regulation
Targeting AMPK and metabolic enzymes, DHM is utilized in pharmaceutical studies to explore pathways related to glycaemic control, insulin sensitivity, and hepatocyte recovery.
02. Oncology Research Foundation
As a secondary metabolite, high-purity Myricetin derivatives are currently under clinical investigation as adjuvant candidates for anti-tumor therapy, focusing on cellular apoptosis pathways.
Industrial Sourcing & Compliance
Tihealth provides full analytical support, including HPLC chromatograms and impurity profile reports for all 98% API shipments. Our production facility is designed to support clinical-stage R&D, ensuring full documentation compliance for international drug development entities.
Hot Tags: dihydromyricetin (dhm) powder | cas 27200-12-0 | ≥ 98.0% hplc | vine tea extract, China dihydromyricetin (dhm) powder | cas 27200-12-0 | ≥ 98.0% hplc | vine tea extract manufacturers, suppliers, factory
You Might Also Like
Send Inquiry